Close

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference Apr 2, 2024 07:00AM
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results Mar 4, 2024 04:01PM
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference Apr 10, 2023 07:00AM
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference Apr 10, 2023 07:00AM
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results Mar 6, 2023 04:01PM
View Older Stories

Mar 6, 2023 04:01PM Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
Apr 5, 2022 07:00AM Cara Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
Apr 5, 2022 07:00AM Cara Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
Mar 14, 2022 06:59AM Needham & Company Reiterates Buy Rating on Cara Therapeutics (CARA)
Mar 2, 2022 06:50AM Needham & Company Reiterates Cara Therapeutics (CARA) at Buy, Expects EMA Approval of I.V. Korsuva in 2Q22
Mar 1, 2022 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 1, 2022 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Aug 24, 2021 06:47AM Cara Therapeutics (CARA) To See $180M in 2024 Revenue from Korsuva - Needham & Company
Apr 29, 2021 11:27AM Cara Therapeutics (CARA) PT Lowered to $26 at Needham & Company After Endpoints Missed in Ph2 KARE Trial
Apr 7, 2021 04:01PM Cara Therapeutics to Present at the 20th Annual Needham Healthcare Conference
Apr 7, 2021 04:01PM Cara Therapeutics to Present at the 20th Annual Needham Healthcare Conference
Feb 25, 2021 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 25, 2021 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Jul 31, 2020 07:24AM Companies with NDRs 7/31
May 13, 2020 06:42AM Companies with NDRs 5/13
Apr 8, 2020 07:00AM Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Conference
Apr 8, 2020 07:00AM Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Conference
Feb 27, 2020 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Feb 27, 2020 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Jul 29, 2019 04:01PM Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 29, 2019 04:01PM Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 25, 2019 05:52AM Cara Therapeutics (CARA) Prices 5.5M Share Common Offering at $23/Sh
Jul 24, 2019 08:42PM Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
Jul 24, 2019 08:42PM Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
Jul 24, 2019 04:42PM Cara Therapeutics (CARA) Announces 5M Share Proposed Offering of Common Stock
Jul 24, 2019 04:01PM Cara Therapeutics Announces Proposed Offering of Common Stock
Jul 24, 2019 04:01PM Cara Therapeutics Announces Proposed Offering of Common Stock
May 29, 2019 10:30AM Cara Therapeutics (CARA) PT Raised to $35 at Needham & Company
Apr 2, 2019 04:01PM Cara Therapeutics to Present at the 18th Annual Needham Healthcare Conference
Apr 2, 2019 04:01PM Cara Therapeutics to Present at the 18th Annual Needham Healthcare Conference
Mar 12, 2019 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 12, 2019 04:01PM Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Jul 23, 2018 04:02PM Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 23, 2018 04:02PM Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 19, 2018 05:49AM Cara Therapeutics (CARA) Prices 4.5M Share Common Offering at $19/Sh
Jul 18, 2018 08:53PM Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
Jul 18, 2018 08:53PM Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
Jul 17, 2018 04:25PM Cara Therapeutics (CARA) Announces Proposed 4.5M Share Common Offering
Jul 17, 2018 04:23PM Cara Therapeutics Announces Proposed Offering of Common Stock
Jul 17, 2018 04:23PM Cara Therapeutics Announces Proposed Offering of Common Stock
May 23, 2018 10:26AM Needham & Company Maintains Bullish View on Cara Therapeutics (CARA) Following IV CR845 License Agreement
Jun 30, 2017 07:49AM Cara Therapeutics (CARA): Two Reasons To Buy Shares - Needham
Apr 5, 2017 04:01PM Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 31, 2017 05:40AM Cara Therapeutics (CARA) Prices 4.45M Shares at $18
Mar 30, 2017 09:35PM Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock
Mar 28, 2017 04:30PM Cara Therapeutics to Webcast Presentation at the 16th Annual Needham Healthcare Conference
Mar 28, 2017 11:26AM Needham and Company Reiterates Buy Rating and $23 PT on Cara Therapeutics (CARA) Following Positive CR845 Phase 2/3 Results
Apr 5, 2016 08:00AM Cara Therapeutics to Webcast Presentation at the 15th Annual Needham Healthcare Conference
Dec 9, 2015 12:12PM Streetinsider.com's Hot Lunchtime Reads 12/9: (DATE) (CARA) (PBY) (SUNE)
Dec 9, 2015 11:29AM Cara Therapeutics (CARA) Bullish Stance Reiterated at Needham & Company on Positive Oral CR845 Phase 2 Osteoarthritis Results
View Older Stories